Given a paragraph and a claim, classify it this way: If the claim contradicts the evidence present in the paragraph, classify the claim as '0'. If the claim has multiple supporting *AND* contradicting evidences, classify the claim as '1'. If the claim has supporting evidence and the paragraph is in overall favor of the claim, then classify the claim as '2'.

[Q]: Paragraph: Such a test could initially be used to select patients for clinical trials of experimental treatments being developed to try to halt progression of Alzheimer's, the researchers said, and may one day move into routine use in doctors' clinics. "Alzheimer's begins to affect the brain many years before patients are diagnosed (and) many of our drug trials fail because by the time patients are given the drugs the brain has already been too severely affected," said Simon Lovestone of Oxford University, who led this work from King's College London. "A simple blood test could help us identify patients at a much earlier stage to take part in new trials and hopefully develop treatments," he said. Alzheimer's is the most common form of dementia, a brain-wasting disease which in 2010 was estimated to be costing the world $604 billion a year. The fatal disease affects 44 million people worldwide, with the number set to triple by 2050, the campaign group Alzheimer's Disease International says. Several big pharma firms including Roche, Eli Lilly, Merck & Co and Johnson & Johnson, are pursuing various approaches to get to the root cause of Alzheimer's and try to find treatments to halt its progression. Yet over the past 15 years, more than 100 experimental Alzheimer's drugs have failed in trial. Lovestone and other experts believe this may be because drug trials are conducted too late, in patients whose condition has already gone too far. A predictive test for use before people develop symptoms would help researchers select the right people for drug trials, and help show whether the experimental drugs are working. Previous studies have found that PET brain scans and tests of lumbar fluid can be used to predict the onset of dementia from people with a less severe condition known as mild cognitive impairment (MCI), but these tests are expensive and invasive, so scientists are keen to develop a cheaper, simpler blood test. MCI includes problems with day-to-day memory, language and attention. It can be an early sign of dementia, or a symptom of stress or anxiety. Around 10 percent of people diagnosed with MCI develop dementia within a year. Apart from regular assessments to measure memory decline, there is currently no accurate way of predicting who will or won't develop dementia. For this study, published in the journal Alzheimer's & Dementia, Lovestone's team used blood samples from 1,148 people - 476 with Alzheimer's, 220 with mild cognitive impairment and 452 elderly controls without dementia. They were analyzed for 26 proteins previously found to be linked with Alzheimer's. The team found 16 of these 26 proteins to be strongly associated with brain shrinkage in either MCI or Alzheimer's and then ran a second series of tests to see which of these could predict which patients would progress from MCI to Alzheimer's. With this second series, they found a combination of 10 proteins capable of predicting with 87 percent accuracy whether people with MCI would develop Alzheimer's disease within a year. Experts in the field welcomed the results but said they should be replicated in larger studies before an Alzheimer's blood test could be rolled out for use in doctors' clinics. "The results reported today are interesting, but as the authors point out there is still a very large amount of work remaining until a usable blood test for Alzheimer's disease becomes available," said Adrian Pini of the MRC Center for Developmental Neurobiology at King's College London. James Pickett, head of research at the Alzheimer's Society, said the research "does not mean that a blood test for dementia is just around the corner". "These 10 proteins can predict conversion to dementia with less than 90 percent accuracy, meaning one in 10 people would get an incorrect result," he said. "Accuracy would need to be improved before it could be a useful diagnostic test." Claim: Study paves the way for a blood test to predict Alzheimer's.
[A]: 2

[Q]: Paragraph: "The march of the Islamic State of Iraq and Syria, or ISIS, across a swath of Iraq has fractured a nation and spurred Republican attacks that the Obama administration is on the verge of ""snatching defeat from the jaws of victory."" Fox News host Jeanine Pirro tied President Barack Obama to the roots of the current assault. On June 14, Pirro offered listeners this insight into the ISIS leader. (ISIS is also called ISIL, for Islamic State of Iraq and the Levant.) ""The head of this band of savages is a man named Abu Bakr al Baghdadi, the new Osama Bin Laden,"" Pirro said. ""A man released by Obama in 2009, who started ISIS a year later. And when Baghdadi left Camp Bucca, where the worst of the worst were held in Iraq, he threatened his American jailers saying, 'I'll see you in New York.' "" A reader wanted to know if Obama actually released Baghdadi, and we decided to look into it. Whatever the truth, the assertion has gained traction. For the president's critics this fits with their disdain for the recent prisoner swap that freed Army Sgt. Bowe Bergdahl in exchange for five Taliban leaders who had been kept at Guantanamo Bay, Cuba. Red State, a conservative blog, used the Baghdadi connection to talk about Obama's ""catch-and-release"" policy. We have two elements to verify. Was Baghdadi in U.S. custody in 2009 and did Obama have a direct connection to his release? We'll deal with them in order. Will the real Abu Bakr al Baghdadi please stand up There have been several articles -- from Slate, and NBC among others -- that place Baghdadi at a detention facility in Iraq called Camp Bucca in 2009 (when Obama would have been president). However, all the talk tracks back to a Daily Beast interview with Army Col. Kenneth King, the former commander of Camp Bucca. That article said King knew Baghdadi at the camp and that he didn't expect to see him become the leader of a spectacularly vicious and brutal movement. ""I'm not surprised that it was someone who spent time in Bucca but I'm a little surprised it was him,"" King said. ""He was a bad dude, but he wasn't the worst of the worst."" In this storyline, Baghdadi was handed over to Iraqi justice system late in 2009 shortly before Camp Bucca closed. However, when PunditFact asked the Defense Department to confirm the story, officials there said Baghdadi was released in 2004, not 2009. ""Ibrahim Awad Ibrahim Al Badry, also known as 'Abu Bakr al-Baghdadi' was held as a 'civilian internee' by U.S. Forces-Iraq from early February 2004 until early December 2004, when he was released,"" the Pentagon said in a statement. ""He was held at Camp Bucca. A Combined Review and Release Board recommended 'unconditional release' of this detainee and he was released from U.S. custody shortly thereafter. We have no record of him being held at any other time."" In short, according to the Defense Department, the man who heads ISIS was released in 2004, long before Obama took office, and was not recaptured. ABC News also has questioned King's recollection, citing a ""a U.S. official"" that Baghdadi was not in American custody in 2009. ""I could be mistaken,"" King told ABC News, ""but I'm 99 percent. He's a dead ringer for the guy I had the run-in with His face is very familiar."" King declined to comment to PunditFact. A troubled detention policy If Baghdadi wasn't in American custody in 2009 as Defense Department officials say, then there's no way Obama could be to blame. But even if he was, the link between the ISIS leader and the American president are flimsy because the framework was set in in 2008 while George W. Bush was president. A little backstory. By July 2005, the United States had four detention facilities -- two near Baghdad, one in the northeastern corner of the country, and Camp Bucca in the far southeastern corner near the Kuwait border. The entire operation was known as Task Force 134. In the course of the war, some 80,000 people passed through these centers, according to the Defense Department. A Pentagon-commissioned study by RAND, a private policy analysis group, described a system that struggled with competing expectations. The incoming population was a mix of captured Sunni and Shiite militants, people rounded up in military raids and ordinary criminals. At times, a blend of overcrowding and sectarian animosities led to riots. The RAND study also said the 2007 ""surge"" -- the addition of 20,000 new troops into Iraq to quell spreading unrest -- pushed detainee levels to over 25,000 people. From 2007-08, Navy Captain Brian J. Bill served as the legal adviser to Detainee Operations for the Multi-National Force in Iraq. Bill described the process of vetting inmates in the U.S. Naval War College journal, International Law Studies. The military established nine review boards, working six days a week, to hear 20 cases each day. Bill reported that when the boards first began they released about 25 percent of the individuals who came before them. Later, that rose to 40 percent. The end of the detention policy At the end Bush's second term in 2008, American and Iraqi negotiators moved toward getting the United States out of the business of holding large numbers of Iraqis. Robert Chesney, professor of international security law at the University of Texas School of Law, said neither side wanted to see the network of detention centers continue. ""Its demise reflected a deliberate policy choice by the United States and Iraq to phase out that system and to rely instead on the Iraqi criminal justice system as the sole mechanism for detention going forward,"" Chesney wrote in 2011. That goal became part of the U.S.-Iraq Status of Forces Agreement, signed in November 2008. Under that agreement the United States agreed to ""turn over custody of such wanted detainees to Iraqi authorities pursuant to a valid Iraqi arrest warrant and shall release all the remaining detainees in a safe and orderly manner."" The United Statescontinued to hold about 200 prisoners judged to pose the greatest risk. They were what remained from a group that numbered about 14,000 at the start of 2009. ""Aside from the so-called 'Deck of Cards' detainees held at Camp Cropper (the top leaders in Saddam Hussein's government), it's hard to imagine how anyone in Washington would have any interest in who we held or released,"" Bill told PunditFact. ""By the end of 2009, it's hard to imagine how we could have continued to hold anyone if the Iraqis themselves didn't decide to detain them."" Our ruling Pirro said that Obama released the current head of ISIS from government custody in 2009. The Defense Department said that the man now known as Baghdadi was released in 2004. The evidence that Baghdadi was still in custody in 2009 appears to be the recollection of an Army colonel who said Baghdadi's ""face is very familiar."" Even if the colonel is right, Baghdadi was not set free; he was handed over to the Iraqis who released him some time later. But more important, the legal contract between the United States and Iraq that guaranteed that the United States would give up custody of virtually every detainee was signed during the Bush administration. It would have required an extraordinary effort to have held on to Baghdadi and there is no evidence that he was on anyone's radar screen, assuming that he was in custody at all in 2009. The U.S.-Iraq agreement drove the release of thousands of detainees in 2009, but Obama had nothing to do with that." Claim: "ISIS leader Abu Bakr al Baghdadi was ""released by Obama in 2009."
[A]: 0

[Q]: Paragraph: In May 2016,photographs and messages reproduced above began circulating on Facebookalong with claims thatlurking underneath labels ofpricey salon-brand hair products purchased through discount retailers were cheaper, lower quality brands. PhotographsshowtheCHI line of hair care products with T.J. Maxx price tag and the label half peeled away to showabottle bearing a less expensive (and presumably lower-quality) hair care product. Most versionsof the claim included an assertion that salon-brand hair products should only be bought at hair salons, not discount retailers. The rumors served as a tacit criticism ofsalon clientele who purchase productfrom third parties rather thanfrom salons or stylists (who would earn commission and meet salon sales goals otherwise). A similar social media rumormaintained thateyelash extensionscan cause "lash lice," a story spreadprimarily by multi-level marketing salespeople hawkingmascara. In another instance, salons and stylists spread a rumor that Pantene (one of the top-selling drugstore hair care brands) can beflammable in combination with popular hair-lightening treatments. Both rumors began with or were passed alongby peopleinvested in the sale of competing products at full price. T.J. Maxx saidthat the CHI products depicted were genuine: At T.J. Maxx, conducting our business with integrity means everything to us and we take pride in offering our customers great values on high quality brand-name products. We have looked into your concerns and can assure you that the contents of the bottle are authentic and are as described on the outer label. We have also confirmed with our supplier that its relabeling of the bottle was appropriate. We thank you for your ongoing patronage of our stores. CHI also responded our questionsabout the photographs. The company explained that the labeling was due in partto manufacturing fluctuations, as well as cutting back on unnecessary waste: Recently, several of our customers have noticed cans of CHI®️ products with labels covering up other products. We sincerely wish to clear up any confusion. The Egyptian Oil and French Oil and other cans you may have seen were originally another CHI®️ product brand we manufactured. Due to a legal challenge that arose concerning the new brand names and designs, we were forced to cease production. As a result of this, we were left with many empty cylinders. To avoid them taking up vital space in our warehouse but most importantly, adding unnecessary waste to landfills, we decided to uphold our environmentally conscious efforts that we have maintained since 1986. We felt we made the right decision by placing original CHI®️ labels over these cylinders and filling them with our CHI®️ formulas. Therefore, the product is authentically made by Farouk Systems with the correct CHI®️ label on them and product inside. We sincerely apologize for any confusion this may have caused our customers. One of the two viral photographs didn't display a T.J. Maxx or Marshall's price tag, strongly suggestingthat the relabeledbottles were indeed notrestricted to non-salon retail environments. CHI's statement affirmedthe relabeled bottleswere in no way different than any other from the brand, whether purchased in a salon or a discount department store. In this instance, both the retailer and the manufacturer said thatthe product packaging was simply repurposed, but the contents remain authentic and identical to products sold in salons and other non-discount retail environments. (In instances where counterfeiting occurs, the companybeing impersonatedis typically the first to object to dilution of their brand.) Claim: Retailers T.J. Maxx and Marshall's sell counterfeit salon products.
[A]:
0